Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 15/20 | 0.49 |
| ▸ | PDE4A | P27815 | 14/20 | 0.49 |
| ▸ | PDE4C | Q08493 | 14/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 14/20 | 0.49 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.38 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2972147 | 1.00 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL5704672 | 0.94 | PDE4B (0.41) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL2968430 | 0.81 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL2980682 | 0.77 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL2972157 | 0.77 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL2972153 | 0.77 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL2971159 | 0.77 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL2980679 | 0.77 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL2980324 | 0.73 | PDE4B (0.48) | PDE4BPDE4APDE4CPDE4DPDE3B | |
| SCHEMBL5704662 | 0.73 | PDE4B (0.48) | PDE4BPDE4APDE4CPDE4DPDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0994100-A1 | 3-ANILINO-2-CYCLOALKENONE DERIVATES | Nikken Chemicals Company, Limited (JP) | 2000-04-19 | — | — | EP | disclosed |